Delek US Holdings, Inc.·4

Mar 20, 8:16 PM ET

Yemin Ezra Uzi 4

Research Summary

AI-generated summary

Updated

Delek US (DK) Director Yemin Ezra Uzi Sells 55,356 Shares

What Happened Yemin Ezra Uzi, a director of Delek US Holdings, sold a total of 55,356 shares in open‑market transactions on March 18, 2026, generating roughly $2,428,475 in proceeds. The sales broke down as: 3,537 shares at $44.20 ($156,335); 8,325 shares at $43.73 ($364,052); 12,969 shares at $44.20 ($573,230); and 30,525 shares at $43.73 ($1,334,858). These were dispositions (sales), not purchases.

Key Details

  • Transaction date: March 18, 2026; Form 4 filed March 20, 2026 (filed within the typical 2‑business‑day window).
  • Reported per‑share prices (shown on filing): $44.20 and $43.73; footnotes state prices reflect weighted averages across multiple executions: one range $43.07–$44.06 and another range $44.07–$44.48. The filer will provide per‑price share counts upon SEC request.
  • Total shares sold: 55,356; total proceeds: approximately $2,428,475.
  • Shares owned after the transaction: not specified in the provided filing.
  • Notable footnote: sales were made pursuant to a Rule 10b5‑1 trading plan (affirmative defense), indicating they were pre‑arranged (Footnote F1).

Context Sales under a 10b5‑1 plan are typically pre‑scheduled and are a common way insiders manage holdings; they do not necessarily signal a change in the insider’s view of the company. For retail investors, purchases (insider buys) often carry more weight as a potential bullish signal, while routine planned sales are less informative about insider sentiment.